Publicacions en col·laboració amb investigadors/es de Universidad Austral de Chile (22)

2021

  1. Deletion of delta-like 1 homologue accelerates renal inflammation by modulating the Th17 immune response

    FASEB Journal, Vol. 35, Núm. 1

2019

  1. Interleukin 17A participates in renal inflammation associated to experimental and human hypertension

    Frontiers in Pharmacology, Vol. 10

2018

  1. Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activation

    Journal of Pathology, Vol. 244, Núm. 2, pp. 227-241

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. Gremlin regulates renal inflammation via the vascular endothelial growth factor receptor 2 pathway

    Journal of Pathology, Vol. 236, Núm. 4, pp. 407-420

2014

  1. Gremlin activates the smad pathway linked to epithelial mesenchymal transdifferentiation in cultured tubular epithelial cells

    BioMed Research International, Vol. 2014

  2. Tubular overexpression of gremlin induces renal damage susceptibility in mice

    PLoS ONE, Vol. 9, Núm. 7

2013

  1. Gremlin is a downstream profibrotic mediator of transforming growth factor-beta in cultured renal cells

    Nephron - Experimental Nephrology, Vol. 122, Núm. 1-2, pp. 62-74

2012

  1. Angiotensin II contributes to renal fibrosis independently of notch pathway activation

    PLoS ONE, Vol. 7, Núm. 7

2011

  1. Effect of eplerenone on hypertension-associated renal damage in rats: Potential role of peroxisome proliferator activated receptor gamma(PPAR-γ)

    Journal of Physiology and Pharmacology, Vol. 62, Núm. 1, pp. 87-94

2010

  1. Regulation of vascular and renal cells by common mediators in health and disease: Role of the renin-angiotensin system in the pathophysiology of hypertension and cardiovascular disease

    Cardiorenal Syndrome: Mechanisms, Risk and Treatment (Springer Milan), pp. 49-63

  2. Statins inhibit angiotensin II/smad pathway and related vascular fibrosis, by a TGF-β-independent process

    PLoS ONE, Vol. 5, Núm. 11

2009

  1. CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-κB

    Journal of the American Society of Nephrology, Vol. 20, Núm. 7, pp. 1513-1526

  2. Ovarian follicular dynamics and plasma steroid concentrations are not significantly different in ewes given intravaginal sponges containing either 20 or 40 mg of fluorogestone acetate

    Theriogenology, Vol. 71, Núm. 4, pp. 676-682

2008

  1. Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation

    Kidney International, Vol. 74, Núm. 5, pp. 585-595

  2. Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways

    Pharmaceutical Research, Vol. 25, Núm. 10, pp. 2447-2461

2007

  1. Interactions between aldosterone and connective tissue growth factor in vascular and renal damage in spontaneously hypertensive rats

    Journal of Hypertension, Vol. 25, Núm. 3, pp. 629-638

  2. Intracellular ascorbic acid inhibits transport of glucose by neurons, but not by astrocytes

    Journal of Neurochemistry, Vol. 102, Núm. 3, pp. 773-782

2006

  1. Long-term treatment with an ACE inhibitor or an AT1 antagonist avoids hypertension-induced inflammation in the kidney

    Journal of Nephrology, Vol. 19, Núm. 6, pp. 725-731